Article Information
PubMed
History
- Published online September 4, 2023.
Copyright & Usage
© 2023 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
Author Information
- Étienne Gaudette, PhD,
- Shirin Rizzardo, RPh MSc,
- Sasha B. Wladyka, MBA MSc,
- Tuhin Rahman, MA,
- Kevin R. Pothier, BSc Pharm RPh
- Institut des politiques, de la gestion et de l’évaluation de la santé (Gaudette); Université de Toronto, Toronto, Ont.; Conseil d’examen du prix des médicaments brevetés (Gaudette, Rizzardo, Wladyka, Rahman, Pothier), Ottawa, Ont.
- Correspondance: Étienne Gaudette, etienne.gaudette{at}utoronto.ca